9999999995-17-003038.txt : 20171122
9999999995-17-003038.hdr.sgml : 20171122
20171122001511
ACCESSION NUMBER: 9999999995-17-003038
CONFORMED SUBMISSION TYPE: EFFECT
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20171121
DATE AS OF CHANGE: 20171122
EFFECTIVENESS DATE: 20171121
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acer Therapeutics Inc.
CENTRAL INDEX KEY: 0001069308
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 760333165
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: EFFECT
SEC ACT: 1933 Act
SEC FILE NUMBER: 333-208314
FILM NUMBER: 171218285
BUSINESS ADDRESS:
STREET 1: 222 THIRD STREET
STREET 2: SUITE #2240
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: (844) 902-6100
MAIL ADDRESS:
STREET 1: 222 THIRD STREET
STREET 2: SUITE #2240
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Opexa Therapeutics, Inc.
DATE OF NAME CHANGE: 20060616
FORMER COMPANY:
FORMER CONFORMED NAME: PharmaFrontiers Corp.
DATE OF NAME CHANGE: 20051011
FORMER COMPANY:
FORMER CONFORMED NAME: PHARMAFRONTIERS CORP
DATE OF NAME CHANGE: 20040816
EFFECT
1
primary_doc.xml
X0101
EFFECT
33
LIVE
2017-11-21
0001654954-17-010672
POS AM
0001069308
Acer Therapeutics Inc.
333-208314